Literature DB >> 6668501

Mycosis fungoides: subcutaneous and visceral tumors, orbital involvement, and ophthalmoplegia.

E G Whitbeck, A S Spiers, M Hussain.   

Abstract

A patient with advanced severe mycosis fungoides presented several unusual features, including prominent lesions of the palate and tongue and an orbital tumor with exophthalmos and ophthalmoplegia. A hitherto undescribed feature was the development of multiple, massive subcutaneous tumors unrelated to the dermis or to lymph nodes, and large tumors in the connective tissues of the buttock, flank, and retroperitoneum. The usual sites of extracutaneous dissemination of mycosis fungoides--lymph nodes, spleen, liver, lungs, and blood--were not demonstrably involved. This may be a new pattern of dissemination for this disease. Of practical importance is the immediate and complete relief of exophthalmos and ophthalmoplegia that was obtained with emergency radiotherapy.

Entities:  

Mesh:

Year:  1983        PMID: 6668501     DOI: 10.1200/JCO.1983.1.4.270

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  4 in total

1.  Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma.

Authors:  B E Cook; G B Bartley; M R Pittelkow
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Corneal perforation due to limbal involvement in Sézary syndrome.

Authors:  Iain Livingstone; Saraswathi Ramamurthi; Suzannah Drummond; Ewan Kemp; Fiona Roberts
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-21       Impact factor: 3.117

Review 3.  Intraocular T-cell lymphoma mimicking a ring melanoma. First manifestation of systemic disease. Report of a case and survey of the literature.

Authors:  O A Jensen; S Johansen; K Kiss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-03       Impact factor: 3.117

4.  Intraocular involvement with subretinal pigment epithelium infiltrates by mycosis fungoides.

Authors:  B C Erny; P R Egbert; I M Peat; K Shorrock; A R Rosenthal
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.